4//SEC Filing
Nohaile Michael 4
Accession 0001209191-23-031485
CIK 0001674930other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:45 PM ET
Size
7.6 KB
Accession
0001209191-23-031485
Insider Transaction Report
Form 4
Nohaile Michael
Director
Transactions
- Award
Common Stock
2023-05-18+2,529→ 6,529 total - Award
Stock Option (Right to Buy)
2023-05-18+3,380→ 3,380 totalExercise: $35.58Exp: 2033-05-17→ Common Stock (3,380 underlying)
Footnotes (2)
- [F1]Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
- [F2]The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001890563
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:45 PM ET
- Size
- 7.6 KB